Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Varea · SciRah

Researcher profile · Semantic Scholar

S. Varea

Share profile

S. Varea — researcher profile on SciRah

h-index: 13
Works: 40
Citations: 1,028

Most-cited papers

A polypill strategy to improve adherence: results from the FOCUS project.
J. Castellano, G. Sanz, J. Peñalvo, S. Bansilal +20 more
2014Journal of the American College of Cardiology298 citations Open access
Semantic Scholar
CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.
V. Ortíz-Maldonado, S. Rives, M. Castellà, Anna Alonso-Saladrigues +36 more
2020Molecular Therapy151 citations Open access
Semantic Scholar
to improve adherence : results from FOCUS ( Fixed-dose Combination Drug for Secondary Cardiovascular Prevention ) Project
J. Castellano, G. Sanz, J. Peñalvo, S. Bansilal +18 more
201495 citations
Semantic Scholar
TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia
C. Perez, Nicolás Martínez-Calle, J. Martín-Subero, V. Segura +13 more
2012PLoS ONE84 citations Open access
Semantic Scholar
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.
A. Oliver-Cáldes, V. González-Calle, Valentín Cabañas, M. Español-Rego +27 more
2023The Lancet Oncology78 citations Open access
Semantic Scholar
Phase II randomised trial of autologous tumour lysate dendritic cell plus best supportive care compared with best supportive care in pre-treated advanced colorectal cancer patients.
M. Caballero-Baños, D. Benítez-Ribas, J. Tabera, S. Varea +13 more
2016European Journal of Cancer56 citations
Semantic Scholar
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura
Maria Cristina Pascual Izquierdo, M. Mingot-Castellano, A. K. Kerguelén Fuentes, José García-Arroba Peinado +36 more
2022Blood Advances47 citations Open access
Semantic Scholar
Economic impact of an electronic alert system to prevent venous thromboembolism in hospitalised patients
R. Lecumberri, E. Panizo, A. Gomez-Guiu, S. Varea +6 more
2011Journal of Thrombosis and Haemostasis31 citations Open access
Semantic Scholar
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
V. Ortíz-Maldonado, S. Rives, M. Español-Rego, Anna Alonso-Saladrigues +33 more
2021Journal for ImmunoTherapy of Cancer24 citations Open access
Semantic Scholar
Academic challenges on advanced therapy medicinal products' development: a regulatory perspective.
Eulàlia Olesti, Yoana Nuevo, M. Bachiller, Elena Guillen +4 more
2024Cytotherapy22 citations Open access
Semantic Scholar
The academic point‐of‐care anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel (ARI‐0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B‐cell non‐Hodgkin lymphoma
N. Martínez-Cibrian, V. Ortíz-Maldonado, M. Español-Rego, A. Blázquez +30 more
2023British Journal of Haematology21 citations Open access
Semantic Scholar
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
A. Agustí, Gastón De Stéfano, A. Levi, X. Muñoz +17 more
2022European Respiratory Journal17 citations Open access
Semantic Scholar
Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double‐blind, randomised, placebo‐controlled trial
M. Palacio, T. Cobo, E. Antolin, M. Ramirez +12 more
2016BJOG: an International Journal of Obstetrics and Gynaecology16 citations Open access
Semantic Scholar
Biomarkers of efficacy and safety of the academic BCMA-CART ARI0002h for the treatment of refractory multiple myeloma.
A. Oliver-Cáldes, M. Español-Rego, A. Zabaleta, V. González-Calle +36 more
2024Clinical Cancer Research13 citations
Semantic Scholar
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma
I. Zugasti, Marta Tormo-Ratera, A. Oliver-Cáldes, J. C. Soler-Perromat +26 more
2024Blood Advances12 citations Open access
Semantic Scholar
Vaginal Progesterone as Maintenance Treatment After an Episode of Preterm Labour (PROMISE) Study: A Multicentre, Double-blind, Randomised, Placebo-Controlled Trial
M. Palacio, T. Cobo, E. Antolin, M. Ramirez +12 more
201712 citations
Semantic Scholar
Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma
Carlos Fernández de Larrea, V. González-Calle, Valentín Cabañas, A. Oliver-Cáldes +22 more
2021Blood10 citations Open access
Semantic Scholar
Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.
J. Maurel, M. Caballero-Baños, J. Milá, J. Tabera +16 more
20158 citations
Semantic Scholar
ARI0002h (Cesnicabtagene Autoleucel), an Academic Point-of-Care B-Cell Maturation Antigen (BCMA)-Directed Chimeric Antigen Receptor (CAR) T-Cell Strategy: Activity and Safety after Fractionated Initial Therapy and Booster Dose in 60 Patients with Relapsed/Refractory Multiple Myeloma
A. Oliver-Cáldes, V. González-Calle, Valentín Cabañas, N. López-Muñoz +33 more
2023Blood6 citations Open access
Semantic Scholar
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trial.
V. Ortiz-Maldonado, N. Martínez-Cibrian, L. Alserawan, M. Español-Rego +43 more
2026The Lancet Haematology5 citations
Semantic Scholar
Phase 1b clinical trial with antigen-specific tolerogenic dendritic in Multiple Sclerosis and Neuromyelitis optica: safety and immunological effects (P2.330)
Irati Zubizarreta Nafarrate, G. Florez, G. Vilà, R. Cabezón +6 more
2017Neurology5 citations
Semantic Scholar
17: Vaginal progesterone as maintenance treatment after an episode of preterm labor (PROMISE Study): a randomized, double blinded, placebo-controlled trial
M. Palacio, T. Cobo, E. Antolin, M. Ramirez +10 more
20125 citations Open access
Semantic Scholar
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients.
J. Mallolas, J. L. Blanco, J. Pich, J. Arnaiz +14 more
2007Revista clínica española (Ed. impresa)5 citations
Semantic Scholar
Long-term follow-up of ARI0002h (cesnicabtagene autoleucel), an academic point-of-care B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell strategy: Activity and safety after fractionated initial therapy and booster dose in 60 patients with relapsed/refractory multiple m
Carlos Fernández de Larrea, A. Oliver-Cáldes, Verónica González De La Calle, Valentín Cabañas +16 more
2024Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Efficacy and safety of the academic anti‐CD19 chimeric antigen receptor T‐cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphoma
N. Martínez-Cibrian, V. Ortíz-Maldonado, M. Español-Rego, L. Alserawan +34 more
2025HemaSphere3 citations Open access
Semantic Scholar
CAR-T Related Cytopenia Profile in Relapsed/Refractory Multiple Myeloma: Results of Patients Treated with ARI0002h, an Academic BCMA-Directed CAR-T Cell
A. Oliver-Cáldes, L. Rodríguez-Lobato, V. González-Calle, N. Tovar +20 more
2022Blood3 citations Open access
Semantic Scholar
Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h
Daniel Munárriz, L. Rodríguez-Lobato, L. López-Corral, Cristina Arnaldos-Pérez +19 more
2025Frontiers in Immunology2 citations Open access
Semantic Scholar
S103: EFFICACY AND SAFETY OF ARI0002H, AN ACADEMIC BCMA-DIRECTED CAR-T CELL THERAPY WITH FRACTIONATED INITIAL THERAPY AND BOOSTER DOSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
C. F. de Larrea, V. González-Calle, A. Oliver-Caldés, V. Cabañas +22 more
2022HemaSphere2 citations Open access
Semantic Scholar
Cesni‐cel (ARI0002h) in ultra‐high‐risk multiple myeloma with plasma cell leukaemia or central nervous system involvement
Carlos Jimenez‐Mira, N. Tovar, N. Martínez-Cibrian, V. González-Calle +22 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
Macrophage Activation Syndrome-Like in Multiple Myeloma Patients Treated with the Academic Bcma-Directed Car-T Ari0002h: Genomic Insights and Clinical Implications
D. Lorca, L. Rodríguez-Lobato, L. López-Corral, Cristina Arnaldos-Pérez +19 more
2025Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
The point-of-care network with the BCMA-directed CART ARI0002h (Cesnicabtagene Autoleucel) in patients with relapsed/refractory multiple myeloma maintains efficacy and safety in real-world data
A. Oliver-Cáldes, N. Tovar, Valentín Cabañas, V. González-Calle +35 more
2025Blood0 citations
Semantic Scholar
Isotype-specific heavy/light chain quantification identifies prognostic biomarkers after ARI0002h BCMA-directed CAR-T cell therapy in multiple myeloma
Anna de Daniel, Joan Mañé Pujol, M. C. Salgado, A. Oliver-Cáldes +20 more
2025Blood0 citations
Semantic Scholar
Academic challenges on ATMPs’ development: a regulatory perspective
Eulàlia Olesti, Yoana Nuevo, Elena Guillen, Juan Bascuas +4 more
20230 citations
Semantic Scholar
Increased Expression Of PD-1 Checkpoint Molecule on Bone Marrow T-Cells from Patients With Multiple Myeloma: Potential Impact on Clinical Outcome?
P. Perez-Montero, A. Paniagua, M. Prieto, L. Llorente +6 more
2019Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
PB2107 UPREGULATION OF PD-1 CHECKPOINT RECEPTOR MOLECULE ON BONE MARROW T-CELLS FROM PATIENTS WITH MULTIPLE MYELOMA, AND ITS POTENTIAL IMPACT ON CLINICAL OUTCOME
P. Perez-Montero, A. Paniagua, M. Prieto, L. Llorente +8 more
2019HemaSphere0 citations Open access
Semantic Scholar
Increasing needs of support on clinical trials in advanced Therapies
S. Varea, J. Pich, A. Cruceta, C. Encinas +1 more
20150 citations Open access
Semantic Scholar
Screening for occult malignancy with 18-F-FDG-PET/CT in patients with unprovoked venous thromboembolism
A. Alfonso, M. Redondo, T. Rubio, B. D. del Olmo +5 more
20120 citations
Semantic Scholar
E-alerts for the prevention of venous thromboembolism in onco-hematological inpatients: pilot evaluation of reasons for physicians' refusal of pharmacological thromboprophylaxis
C. Lazo, R. Lecumberri, S. Varea, A. Alfonso +4 more
20120 citations
Semantic Scholar
412 ISOLATION AND DIFFERENTIATION OF BONE MARROW-DERIVED ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH ADVANCED LIVER CIRRHOSIS FOR THERAPEUTICAL USE
V. Fernández-Ruiz, D. D'Avola, M. Méndez, S. Carrillo +9 more
20120 citations
Semantic Scholar
PO-02 Incidence of venous thromboembolism and prophylaxis use in ambulatory cancer patients receiving chemotherapy
E. Panizo, R. Lecumberri, S. Varea, Alberto García-Mouriz +1 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Español-Rego×16
Invite
M. Español-Rego — researcher profile on SciRah
A. Oliver-Cáldes×14
Invite
A. Oliver-Cáldes — researcher profile on SciRah
L. Rodríguez-Lobato×14
Invite
L. Rodríguez-Lobato — researcher profile on SciRah
V. Ortíz-Maldonado×12
Invite
V. Ortíz-Maldonado — researcher profile on SciRah

Invite

N. Tovar — researcher profile on SciRah

Carlos Fernández de Larrea×12

Invite

Carlos Fernández de Larrea — researcher profile on SciRah

J. Moraleda×11

Invite

J. Moraleda — researcher profile on SciRah

Valentín Cabañas×10

Invite

Valentín Cabañas — researcher profile on SciRah

Eulàlia Olesti×10

Invite

Eulàlia Olesti — researcher profile on SciRah

J. Sáez-Peñataro×9

Invite

J. Sáez-Peñataro — researcher profile on SciRah

J. L. Reguera×9

Invite

J. L. Reguera — researcher profile on SciRah

Invite

L. Rosiñol — researcher profile on SciRah